Last year, for the second year in a row, I handed out awards to the top players in the stem cell universe. There were the Knoepfler Lab 2011 Stem Cell Awards. If you read that post you can see the full spectrum of the awardees, which included Matt Bohrs for stem cell political cartoon of the […]
Knoepfler Blog Stem Cell Awards 2012: Real prizes, nominate your favorites! Read More »
I regularly do an update on the publication trends in the iPS cell field and these have been posts that readers have found especially useful. Here was a popular update from 2010 and another one from 2011 that included a who’s who of the iPS cell field more broadly as well beyond just publishing. Then
Part 1 on iPS cell 2012 publication trends: an unusual year Read More »
The NY Times has just run a 3-part, high-profile series on the developing biomedical area of adult stem cell-based tissue regeneration and organ transplant. See picture above (from NY Times) of rat hearts and lungs being “washed” of cells to be used as scaffolds for growing new organs. You can read the three articles here:
Very cool adult stem cell and organ regeneration series in NY Times Read More »
For a while there this weekend, it had seemed that the upcoming adult stem cell meeting in Houston keynoted by Guv Rick Perry had lost something important. Its website! Oops. Now that all seems fixed. Whew. However, a second stem cell-related entity seems to have made the same mistake, but this time it appears likely
Another stem cell website goof: ICMS loses its patient website Read More »
What’s the deal with Nordstrom and stem cells? Are they going to rename themselves “Nordstem”? I grew up in Bellevue, WA, home of the Nordstrom’s family and of the Nordstrom department store chain. I believe the flagship store was just across Lake Washington in Seattle. I don’t like shopping as perhaps most guys feel, but
Nordstrom hawking super expensive, non-FDA approved stem cell cosmetic drugs Read More »
There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically
Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »
I think the number of main stream media articles on stem cells that are dumb is increasing…some weeks it’s hard to choose which is the dumbest in fact. This week it is not so hard to pick. The Daily Mail has an epic fail piece on a British company’s dubious stem cell treatment for wrinkles
Dumb stem cell article of the week goes to the Daily Mail on stem cell cosmetics Read More »
The founder of Korean stem cell corporation, RNL Bio, Dr. Jeong-Chan Ra, may be most well-known in the U.S. for his association with Texas Stem Cell Clinic, Celltex, which gave Guv Rick Perry his stem cell transplant. RNL Bio is also the first major company to be sued in U.S. federal court for fraud over
Francisco Morales and Lawrence Stowe, have pleaded guilty to federal charges related to dubious stem cell treatments. The pair pled guilty to conspiracy charges related to introducing “misbranded and unapproved new drugs into interstate commerce”. The drugs in question? Stem cells. Patrick J. Holland of the FDA said “the FDA is committed to investigating those
Stem cell frauds Morales and Stowe plead guilty to federal charges: who’s next? Read More »
For years now we’ve had a war in the world of stem cells. The war has been primarily centered on embryonic stem cell research (ESCR). The reason I call it a “war” is that opponents of ESCR have declared a “culture war” on ESCR and ESC researchers. I don’t like the term “war”, but if
Update on stem cell culture war: from Pepsi to Personhood & Romney to rogue clinics Read More »